The Hidden Lung Infection Impacting Millions: World NTM Day Puts Spotlight on Awareness
With Annual NTM Case Rates Rising, Patients and Providers Are Urged to Recognize the Symptoms and Risks MIAMI, Aug. 4,...
Year: 2025
Waters Corporation (NYSE: WAT) Reports Second Quarter 2025 Financial Results
Highlights Sales of $771 million exceeded guidance range; grew 9% as reported and 8% in constant currencyGAAP EPS of $2.47...
Turbine to Simulate Hard-to-Treat Cancer Populations with AI for Identification of Novel Dependencies through Collaboration with MSD
LONDON, UK and BUDAPEST, HUNGARY, Aug. 4, 2025 /PRNewswire/ -- Turbine, a leading developer of cell simulations with AI, today...
Waymark Signal Achieves 85% Accuracy in Predicting Medicaid Care Gaps, Study in npj Digital Medicine Shows
Peer-reviewed research demonstrates dramatic improvement in identifying and closing quality gaps for Medicaid patients, outperforming current methods by 35 percentage...
P-n-T Data Corp. Launches Post-n-Track Gen 3 to De-Risk Healthcare Data Sharing and Residency
Combating healthcare data cyber risk at the source by eliminating unnecessary PHI/PII exposure MIDDLETOWN, CT / ACCESS Newswire / August...
Rapid Dose Therapeutics Submits QuickStrip(TM) Nicotine Product for Health Canada Approval
Innovative Oral Nicotine Delivery Technology Targets Safer Alternative for SmokersBurlington, Ontario--(Newsfile Corp. - August 4, 2025) - Rapid Dose Therapeutics...
Munchkin Revolutionizes Breastfeeding Support with Groundbreaking Innovation Backed by New Clinical Research
Coinciding with National Breastfeeding Awareness Month, new U.S. clinical research study shows 87% of moms using Munchkin’s Flow Nipple Shield+...
Hyperfine Achieves Clinical Milestone Ahead of Plan With 100th Patient Enrolled in Neurology Office Study Using the Next-Generation Swoop® System
NEURO PMR study evaluates the clinical utility and patient experience of AI-powered portable MRI in an outpatient settingGUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine,...
Hyperfine Achieves Clinical Milestone Ahead of Plan With 100th Patient Enrolled in Neurology Office Study Using the Next-Generation Swoop® System
NEURO PMR study evaluates the clinical utility and patient experience of AI-powered portable MRI in an outpatient settingGUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine,...
TruBridge Re-Establishes Partnership With Jackson Parish Hospital to Boost Financial Performance and Outcomes
MOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ: TBRG), a leading healthcare solutions company, welcomes back Jackson Parish Hospital, a 25-bed critical access...
BioHarvest Sciences to Host Second Quarter 2025 Earnings Call on August 11 at 8:00 a.m. Eastern Time
Rehovot, Israel--(Newsfile Corp. - August 4, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a...
STEEMCC Initiative to Transform Care Coordination and Behavioral Health Access in the Virgin Islands
WASHINGTON, DC / ACCESS Newswire / August 4, 2025 / The St. Thomas East End Medical Center Corporation (STEEMCC) has...
Duly Health and Care Opens New Multi-Specialty Clinic in Schaumburg
Expanding access to high-quality, physician-directed care in the northwest suburbs DOWNERS GROVE, IL / ACCESS Newswire / August 4, 2025...
CASI Pharmaceuticals Announces FDA Clearance of IND Application for CID-103 in Renal Allograft Antibody-Mediated Rejection (AMR)
CID-103 is a potential best-in-class, anti-CD38 monoclonal antibody; binds to unique CD38 epitopePhase 1 study in adults with active and...
CarePayment Recognized as #1 Patient Financing Vendor in Black Book’s 2025 Revenue Cycle Management Rankings
TAMPA, FL / ACCESS Newswire / August 4, 2025 / CarePayment, a leading provider of patient financing solutions, has been...
Phase 1 Clinical Ttrial of HIV Vaccine Starts in Africa to Evaluate Immune Responses to Highly Networked HIV T-Cell Epitopes
Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given....
Modular Medical Announces MODD1 Cartridge Line Validated for Human-Use Production
-Line has been in production at risk since early July- Production to continue until late August when conversion to Pivot...
Noom Launches Microdose GLP-1 Program, Enabling Weight Loss Without the Side Effects and Priced at $119 to Start, Including Medication and Microhabits Program
70% of Noom members receiving microdoses of GLP-1 with lifestyle support report no side effects, while experiencing significant weight loss...
Vor Bio Appoints Seasoned Biotech Executive Dallan Murray as Chief Commercial Officer
Experienced commercial leader to shape launch strategy and global market readiness for telitacicept and future pipeline opportunitiesCAMBRIDGE, Mass., Aug. 04,...
Corporate Update, August 2025
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- From Dr. Neil Maresky, CEO, Psyence BioMed (NASDAQ: PBM) Dear Shareholders, Thank...